Shruti Bhat PhD, MBA, Lean Six Sigma Black Belt
  • Home
  • About Shruti
  • Consulting
  • Workshops
  • Patents
  • Articles
    • Case Studies
    • Innovation Portfolio Development & Patents
    • Drugs-in-the- making
    • Culture Change & Business Transformation
    • Operational Excellence, Quality & Continuous Improvement
  • Books
  • Digital
  • Blog
  • Videos
  • Contact

Novel Oral Controlled Drug Delivery Systems.

5/18/2009

0 Comments

 
Technology in the field of controlled delivery has gone forward at a rapidly accelerating pace and promises many new and exciting developments.

Research on novel oral controlled release delivery systems focuses on increasing gastric retention or gastro-intestinal absorption.  Currently, retention time is quite variable and depends on the individual.  Gastric platforms have been developed that adhere to the stomach wall, thereby increasing gastric residence time and allowing for prolonged duration of therapy.
Novel controlled release drug delivery systems
Latest Advances in Oral Transmucosal Delivery:

The controlled delivery of macromolecular drugs represents one of the greatest challenges in drug delivery. Transmucosal delivery across the tissues of the oral cavity is an attractive means for non-invasively administering such drugs.  

Oral transmucosal (OTM) administration offers several advantages for controlled drug delivery. Viz. bypass hepatic first pass effect.  The oral mucosa can be generally divided into two categories: Keratinized tissues (gingiva and palate) and non-keratinized epithelial tissues (sublingual & buccal).  The non-keratinized oral mucosa is highly permeable and blood flow to the oral mucosa is exceptionally high. 

In addition, an oral mucosal tissue is readily accessible and localization of dosage form with a defined surface area over extended periods should maximize absorption and provide higher degree of control and reproducibility relative to other mucosal delivery routes.  These factors combined with the relatively rugged nature of the oral mucosa to physical and chemical injury make OTM an attractive mode for macromolecular drug administration.


One example of OTM based DDS is a bilayered tablet, which consists of a biocompatible adhesive layer that adheres to the gingiva and an active layer containing drug and optionally a tissue permeation enhancer.  The active layer contacts the inner surface of the upper lip opposite the gingival application site and delivers the drug as the entire tablet dissolves.  

​The choice of formulation components of the adhesive and active layers of the OTM system is dependent on the desired release characteristics of the active compound, dissolution time can be varied based on the physicochemical properties of the drug and the profile desired by the glucagon-like peptide (GLP-1) containing tablet for NIDDM therapy. 

Potentially therapeutic plasma levels of GLP-1 were achieved after administration of a single OTM tablet in type 2 diabetic patients.  The peptide had marked glucose lowering effect during the first two hours.  The bioavailability of GLP-1 after oral transmucosal administration was estimated as 47% relative to subcutaneous administration.
Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement

    New Book Released!

    top ten strategic decision-making tools for operational excellence

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    5S
    Agile
    Artificial Intelligence
    Automation
    Balanced Score Card
    Biotechnology
    Books
    Business Turnaround
    Case Studies
    Change Management
    Chemical Industry
    CMMI
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Food Industry
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    Nanotechnology
    Operations
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    Robotics
    Scrum
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    TQM
    Videos
    Voice Of Customer
    Workshops

    Shruti's books...

    Picture
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    Picture
    how to overcome challenges of creating effective teams
    how to lead a successful business transformation

    ​Micro-Learning
    ​Partner

    Picture

    Publishing Partner

    fast read books, business management books, health and wellness books, spiritual guidance books, best online book store

    Wellness
    ​Partner

    Picture
© Copyright 1992- 2022 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media